Skip to Content

Tag: MiniMed


Also Noted

MiniMed expands board to 11 members

June 30, 2026HME News Staff

NORTHRIDGE, Calif. – MiniMed has announced that David Endicott and Linnea Burman have joined its board of directors, expanding the board from nine to 11 members. As MiniMed builds its next chapter as an independent company, Endicott, CEO of Alcon, adds experience scaling global health care businesses, leading through a public market separation and operating at board level in a large, regulated category, the company says. "David has done this before," said Que Dallara, CEO of MiniMed....

Board of Directors, Diabetes, Insulin pump, MiniMed


Read Full Articlered right arrow icon

News

In brief: Molina’s next implementation, Medline’s fire response, MiniMed’s Flex

June 22, 2026HME News Staff

YARMOUTH, Maine – Molina Healthcare of Iowa will implement a new DME Navigator program for members in all lines of business starting in the fall. The payer also has plans to use the platform in Nebraska and Wisconsin. What durable medical equipment providers in Iowa need to know: Molina is subcontracting the DME network to Optum for the in-scope DME products and services. CareCentrix will contract, credential and manage a network of DME providers rendering in-scope products and services...

DME Navigator, fire, Insulin pump, Medline, MiniMed, MiniMed Flex, Molina Healthcare, third-party administrators


Read Full Articlered right arrow icon

Also Noted

MiniMed launches Flex insulin pump in US

June 22, 2026HME News Staff

NORTHRIDGE, Calif. – MiniMed has announced its first commercial launch of the MiniMed Flex system in the United States – the company’s first app-controlled pump and its smallest insulin pump yet. The system launches with Simplera Sync sensor, a disposable, all-in-one sensor with easy two-step insertion. The launch with the Instinct sensor, made by Abbott, will follow later this summer.  "For too long, people managing diabetes have had to choose between effective therapy...

Diabetes, Insulin pump, Medtronic, MiniMed, MiniMed Flex


Read Full Articlered right arrow icon

Also Noted

Medtronic’s MiniMed board sees shake up

May 19, 2026HME News Staff

NORTHRIDGE, Calif. – Brett Wall, a class II director of MiniMed Group’s board of directors, has resigned following his departure as executive vice president and president of the neurosciences portfolio of Medtronic, the parent company of MiniMed, according to a Securities and Exchange Commission (SEC) filing. Wall, who was also a member of the board’s Nominating and Corporate Governance Committee, was nominated to the MiniMed board by Medtronic. Scott Cundy will fill his vacancy...

Board of Directors, Brett Wall, Continuous Glucose Monitor (CGM), Diabetes, MiniMed


Read Full Articlered right arrow icon

News

In brief: Conduit Health’s raise, Quipt’s new phase, MiniMed’s debut

March 17, 2026HME News Staff

NEW YORK – Conduit Health, a consumer-oriented provider of insurance-covered medical supplies and services for Medicare and Medicaid patients, has announced a $17 million Series A to expand its vertically-integrated model that it says brings clinical care, insurance authorization and medical supply fulfillment together under one coordinated structure. In just 16 months since its public launch, Conduit has delivered supplies to more than 50,000 patients, while increasing its product catalog...

Conduit Health, Medtronic, MiniMed, Quipt Home Medical


Read Full Articlered right arrow icon

Also Noted

Medtronic’s MiniMed joins Nasdaq

March 17, 2026HME News Staff

GALWAY, Ireland, and NORTHRIDGE, Calif. – MiniMed Group, a subsidiary of Medtronic, has begun trading on the Nasdaq under the ticker symbol “MMED” in connection with its initial public offering (IPO). "Today marks an exciting milestone for both MiniMed and Medtronic,” said Geoff Martha, Medtronic chairman and CEO. “Despite a challenging market backdrop shaped by geopolitical uncertainty, the teams successfully executed an oversubscribed offering and the second largest...

Diabetes, Initial Public Offering (IPO), Medtronic, MiniMed, Nasdaq


Read Full Articlered right arrow icon

Also Noted

Medtronic reports Q3 earnings, sees diabetes growth

February 17, 2026HME News Staff

GALWAY, Ireland – Medtronic reported revenue of $9 billion for its third quarter of fiscal year 2026 (FY26), which ended Jan. 23, 2026. Of that, diabetes business revenue was $796 million, an increase of 14.8% as reported and 8.3% organic, led by double-digit strength in international markets. In May 2025, Medtronic announced it would separate its diabetes business into a new standalone company, which represented 8% of revenue and 4% of segment operating profit...

Diabetes, Medtronic, MiniMed


Read Full Articlered right arrow icon

News

In brief: Cardinal, Medtronic stand up Rx channels for diabetes 

January 13, 2026HME News Staff

DUBLIN, Ohio – Cardinal Health has introduced ContinuCare Pathway, a pharmacy-to-supplier referral pathway program designed to help retail pharmacies seamlessly refer patients to Cardinal Health at-Home Solutions for the fulfillment and home delivery of diabetes supplies, including continuous glucose monitors (CGMs).  “Providing diabetic supplies to patients covered under a medical benefit can create administrative burden on a pharmacy,” said Rob Schlissberg,...

Cardinal Health, Cardinal Health at-Home Solutions, Medtronic, MiniMed, Pharmacy


Read Full Articlered right arrow icon

Vendors

Medtronic builds pharmacy channel for MiniMed insulin pump 

January 12, 2026HME News Staff

MINNEAPOLIS – Medtronic Diabetes has expanded U.S. pharmacy formulary access for its MiniMed 780F insulin pump through agreements with major pharmacy benefit managers (PBMs) and group purchasing organizations (GPOs), including Ascent and Zinc.  These agreements also include access to the company's expanded CGM portfolio – Simplera sensor, Simplera Sync sensor, and Instinct sensor, made by Abbott – and build...

Diabetes, Insulin pump, Medtronic, MiniMed


Read Full Articlered right arrow icon

Also Noted

Medtronic starts IPO process for MiniMed 

December 23, 2025HME News Staff

GALWAY, Ireland – Medtronic has announced that its diabetes business, which will operate under the name MiniMed, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO) of newly issued common stock. The separation is expected to be completed through a series of capital markets transactions, with a preferred path of an IPO and subsequent split-off. MiniMed intends...

Diabetes, Initial Public Offering (IPO), Medtronic, MiniMed


Read Full Articlered right arrow icon